Savara Inc (SVRA)
1.28
-0.01 -0.78%
NASDAQ
Jul 28, 10:08
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.70 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -44.41M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 145.46M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | 0.8306 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -9.597M |
| Return on Equity | Upgrade |
View All SVRA News
News
-
WireHeadlineTime (ET)
-
Yahoo07/26 15:48
-
Yahoo07/01 10:25
-
Yahoo06/30 10:47
-
Yahoo06/22 08:54
-
Yahoo06/18 12:11
-
Yahoo05/26 08:05
-
SA Breaking News05/24 14:59
-
Yahoo05/20 05:24
-
Yahoo05/17 08:05
-
Yahoo05/14 08:05
-
SA Breaking News05/13 17:06
-
Yahoo05/13 16:05
-
SA Breaking News05/05 08:24
-
SA Breaking News04/01 11:21
-
SA Breaking News03/31 08:26
-
PR Newswire03/17 08:30
-
SA Breaking News03/17 08:24
-
SA Breaking News03/16 12:41
-
PR Newswire03/16 10:22
-
SA Breaking News03/16 08:29
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/06/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/06/2021 16:30 EST | Earnings Calls | Q2 2021 Earnings Call |
| 06/10/2021 16:00 EST | AGM | 2021 Annual General Meeting |
| 05/13/2021 | Earnings Results | Q1 2021 Earnings Results |
| 11/05/2020 | Earnings Results | Q3 2020 Earnings Results |
| 08/06/2020 16:30 EST | Earnings Calls | Q2 2020 Earnings Call |
| 08/06/2020 | Earnings Results | Q2 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases. It offers products such as AeroVanc, for the treatment of persistent methicillin-resistant staphylococcus aureus and lung infection in cystic fibrosis patients; Molgradex, for the treatment of autoimmune pulmonary alveolar proteinosis and Aironite, an inhaled nebulized sodium nitrite solution to treat heart failure with preserved ejection fraction. All the business activity of the firm functions through the region of the United States.
- URL: http://www.savarapharma.com
- Investor Relations URL: https://savarapharma.com/investors/events-presentations/
- HQ State/Province: Texas
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 06, 2021
- Last Earnings Release: May. 13, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 1.28 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- SVRA Tweets Stocktwits
Advertisement
